Neuromedin B (porcine)
Cat. No. 1908
Biological ActivityMammalian bombesin-like peptide and endogenous ligand for the neuromedin B receptor (IC50 = 2 nM); first isolated from pig spinal cord. Regulates endocrine and exocrine secretion, smooth muscle contraction, blood pressure, feeding and cell growth.
(Modifications: Met-10 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Ohki-Hamazaki et al (2000) Neuromedin B. Prog.Neurobiol. 62 297. PMID: 10840151.
Sainz et al (1998) Four amino acid residues are critical for high affinity binding of neuromedin B to the neuromedin B receptor. J.Biol.Chem. 273 15927. PMID: 9632639.
Minamino et al (1983) Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. Biochem.Biophys.Res.Commun. 114 541. PMID: 6882442.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Neuromedin B (porcine) from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Neuromedin B (porcine), supplier, Mammalian, bombesin-like, peptide, GRP-Preferring, Receptors, BB1, BB2, BB3, Gastrin-Releasing, Peptide-Preferring, NMB-Preferring, Neuromedin, B-Preferring, Bombesin, agonists, NeuromedinB, (porcine), Tocris Bioscience, Bombesin Receptor products
Find multiple products by catalog number
New Products in this Area
Non-peptide apelin receptor agonistBML 111
FPR2 (lipoxin A4 receptor) agonistAmylin (rat)
Potent endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptorsCalcitonin (human)
Endogenous calcitonin receptor agonist; inhibits bone resorptionSpexin
Potent GAL2/3 agonist; exhibits anxiolytic effects in vivoMM 54
Potent apelin receptor antagonistMSG 606
Potent human MC1 receptor antagonist; also MC3 and MC5 partial agonist
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.